JOHANNA GRAY

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions

Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P) Implementation of Medicaid Community Engagement requirements

FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY27 appropriations for breast cancer research FY27 appropriations for cancer prevention and control

Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft

Blood and plasma safety and awareness Bleeding disorders awareness Fostering Effective Diagnosis and Treatment for Underserved Populations (FED UP) with Bleeding Disorders Act (H.R. 8794)

Funding for federal hemophilia programs in FY27 House and Senate Labor-HHS Appropriations bills NIH FY27 appropriations

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements

Funding for federal hemophilia programs at CDC and HRSA for FY27 Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics

Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs

Reimbursement for healthcare services provided by epilepsy centers

HR 1189/S 494 National Plan for Epilepsy Act

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)

FY26 and FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY26 and FY27 appropriations for breast cancer research FY26 and FY27 appropriations for cancer prevention and control

Hemophilia research, prevention, surveillance and service programs and issues; advancing care for women and girls with bleeding disorders

Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act

Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency

Funding for federal hemophilia programs at CDC and HRSA for FY26 Funding for federal hemophilia programs at CDC and HRSA for FY27

HR 1189/S 494 National Plan for Epilepsy Act

Reimbursement for healthcare services provided by epilepsy centers

FY26 appropriations for the National Breast and Cervical Cancer Early Detection Program FY26 appropriations for breast cancer research FY26 appropriations for cancer prevention and control

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease

H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid

Blood and plasma safety and awareness Bleeding disorders awareness

H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act

H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.

Reimbursement for healthcare services provided by epilepsy centers HR 1, One Big Beautiful Bill Act Letter to House and Senate Leaders requesting extension of expiring Telehealth services under Medicare

HR 1, One Big Beautiful Bill Act

HR 1189/S 494 National Plan for Epilepsy Act

Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions

H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid

Blood and plasma safety and awareness Bleeding disorders awareness

H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act

H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.

Reimbursement for healthcare services provided by epilepsy centers HR 1, One Big Beautiful Bill Act Letter to House and Senate Leaders requesting extension of expiring Telehealth services under Medicare Comments RE: Proposed Rule on Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Proposed Rule (CMS-1834-P) Comments RE: Proposed Rule on Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program (CMS-1832-P)

HR 1, One Big Beautiful Bill Act

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing. requirements with respect to diagnostic and supplemental breast examinations. Implementation of the Affordable Care Act HELP Copays Act (S.864); a bill to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. Cancer survivorship issues Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Comments Re: Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability (CMS-9884-P)

H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid

Blood and plasma safety and awareness Bleeding disorders awareness

H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act

H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits

Reimbursement for healthcare services provided by epilepsy centers Telehealth services HR 1, One Big Beautiful Bill Act

HR 1, One Big Beautiful Bill Act

HR 1189/S 494 National Plan for Epilepsy Act

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging

Access to Breast Cancer Diagnosis (ABCD) Act; a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing. requirements with respect to diagnostic and supplemental breast examinations. Safe Step Act; a bill to require a group health plan to establish an exception to medication step-therapy protocol in specified cases. Implementation of the Affordable Care Act HELP Copays Act (/S.864); a bill to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to copay accumulator and maximizer adjustors Policies related to the extension of enhanced advanced premium tax credits Healthcare Affordability Act of 2024 (H.R. 247 / S. 46) a bill to expand eligibility for the refundable credit for coverage under a qualified health plan. Protect patients from substandard and junk insurance products

Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid

Blood and plasma safety and awareness Bleeding disorders awareness

Implementation of the Affordable Care Act The HELP Copays Act (HR 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to PBM regulation Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid PBM Reform amendments to Medicaid and Medicare in Continuing Resolution draft legislation

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits

Reimbursement for healthcare services provided by epilepsy centers Telehealth services

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY25 House and Senate Labor-HHS Appropriations bills (H.R. 9029/S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025) Policies related to report language on the implementation of the Medicare Prescription Payment Plan. Policies related to the transparent use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening.

Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to ICD-10 code for inflammatory breast cancer Comments in response to FDA guidance, Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice (FDA-2024-D-2052) Comments in response to proposed updates to HRSA-Supported Womens Preventive Services Guidelines

Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 3884/S. 1852)

Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Safe Step Act (HR 2630/ S. 652) Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program (CMS-9888-P) Congressional sign-on letter to HHS/Treasury/Labor asking them to release the promised rule closing the EHB loophole for ERISA plans

Drug Enforcement Administration (DEA) rules to extend telehealth prescribing of controlled substances and other regulatory issues

Reimbursement for healthcare services provided by epilepsy centers Telehealth services

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Congressional sign-on letter to HHS/Treasury/Labor asking them to release promised rule closing the EHB loophole for ERISA plans Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program (CMS-9888-P)

Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency

Blood and plasma safety and awareness Bleeding disorders awareness Securing Equal Access to Research, Care, and Health (SEARCH) Act Creating Hope Reauthorization Act of 2024 (HR 7384) Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V) (CFPB-2024- 0023)

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program

Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Letter in response to Congressional Framework on Reforming the National Institutes of Health Letter in response to FDA Draft Guidance on Diversity Action Plans

Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R.3086/S.5141 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Community Health Worker Access Act which is a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs (S. 3892) Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Comments in response to CY 2025 Medicare Physician Fee Schedule Comments in response to CY 2025 Medicare HOPPS proposed rule

Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Comment letter in response to CY 2025 Medicare Physician Fee Schedule proposed rule

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) AIMED Alliance Citizens Petition re drug importation and alternative payment models

Letter on Drug Enforcement Administration (DEA) rules to extend telehealth prescribing of controlled substances and other regulatory issues.

Reimbursement for healthcare services provided by epilepsy centers Telehealth services

Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Reducing Hereditary Cancer Act (HR 1526/S. 765) CONNECT for Health Act (H.R. 4189/S. 2016) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Implementation of Lymphedema Treatment Act Preserving and expanding access to Medicaid Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Community Health Worker Access Act which is a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs (S. 3892) Equitable Community Access to Pharmacist Services Act (S. 2477/H.R. 1770) Access to Genetic Counselor Services Act (H.R.3876/S.2323) Comments Re: Medicaid; CMS Enforcement of State Compliance with Reporting and Federal Medicaid Renewal Requirements Under Section 1902(t) of the Social Security Act (CMS-2447-IFC) Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P). Comments RE: Request for Information on Medicare Advantage Data

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program SUSTAIN 340B ACT - Draft Senate 340B reform legislation

Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act Coverage for Telehealth Services Closing the Medicaid coverage gap Issues related to 1115 Waivers in Medicaid Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Sickle Cell Disease Comprehensive Care Act (H.R. 1672/S.996) PROTECT Rare Act (H.R. 6094) MVP Act (H.R. 2666)

Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency

Funding for federal hemophilia programs

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Letter to the Committee on Education and the Workforce Request for Information on Employer-Sponsored Insurance and Employee Retirement Income Security Act (ERISA)

Epilepsy Program Grants

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Medicare Part D, six protected classes of drugs

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Cancer Drug Parity Act (S. 2039) Telehealth Benefit Expansion for Workers Act (H.R. 824) Association Health Plans Act (H.R. 2868) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act, including comments on proposed rule re: Federal Independent Dispute Resolution Operations Find It Early Act (H.R.3086); a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation Policies related to copay accumulator adjustors Comments related to the Mental Health Parity and Addiction Equity Act Letter to Committee on Education and the Workforce Request for Information on Employer-Sponsored Insurance and Employee Retirement Income Security Act (ERISA)

Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Policies related to insurance coverage and COVID-19 Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Safe Step Act (HR 2630 / S 652) Implementation of the No Surprises Act Policies related to short-term, limited duration insurance Comments related to the Mental Health Parity and Addiction Equity Act Policies related to copay accumulator adjustor programs Letter to the Committee on Education and the Workforce Request for Information on Employer-Sponsored Insurance and Employee Retirement Income Security Act (ERISA)

Implementation of the No Surprises Act Blood and plasma safety and awareness Bleeding disorders awareness Issues related to plasma donation in border states Issues related to access to residential substance use disorder and mental health facilities for individuals with bleeding disorders Sickle Cell Care Expansion Act (H.R. 3100/S.1423) Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 3884/S. 1852) Menstrual Equity for All Act (H.R. 3646)

Appropriations for the CDC

Support for policies which ensure health insurance provides comprehensive benefits and is affordable and accessible for patients Patient Priorities for the Notice of Benefit and Payment Parameters HR 824, the Telehealth Benefit Expansion for Workers Act Comments related to the Mental Health Parity and Addiction Equity Act

Policies related to health care and access to services for children and youth with special health care needs Support for caregivers Policies related to school-based seizure protections for kids with epilepsy

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Hemophilia Gene Therapy coverage and payment policy request for meeting with CMS HR 3561 Section related to Medicaid transparency and drug pricing Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P).

Funding for federal hemophilia programs

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Letter to the Committee on Education and the Workforce Request for Information on Employer-Sponsored Insurance and Employee Retirement Income Security Act (ERISA)

Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy Policies related to implementation of the Inflation Reduction Act, including implementation of Medicare drug negotiation program and the orphan drug exclusion Comments Re: Medicaid; CMS Enforcement of State Compliance with Reporting and Federal Medicaid Renewal Requirements Under Section 1902(t) of the Social Security Act (CMS-2447-IFC) Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P).

Appropriations for the CDC

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Medicare Part D, six protected classes of drugs

Epilepsy Program Grants

Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy Comments on Processes for Assessing Compliance with Mental Health Parity and Addiction Equity in Medicaid and CHIP Policies related to implementation of the Inflation Reduction Act, including implementation of Medicare drug negotiation program and the orphan drug exclusion

Policies related to health care and access to services for children and youth with special health care needs Support for caregivers Policies related to school-based seizure protections for kids with epilepsy

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Cancer Drug Parity Act (S. 2039) Telehealth Benefit Expansion for Workers Act (H.R. 824) Association Health Plans Act (H.R. 2868) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act Find It Early Act (H.R.3086); a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation Policies related to copay accumulator adjustors Comments related to the Mental Health Parity and Addiction Equity Act

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)

Issues related to reimbursement for hemophilia services and treatments in Medicare Issuers related to reimbursement for hemophilia services and treatments in Medicaid HR 3561 Section related to Medicaid transparency and drug pricing Hemophilia Gene Therapy coverage and payment policy request for meeting with CMS

Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Policies related to insurance coverage and COVID-19 Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Safe Step Act (HR 2630 / S 652) Implementation of the No Surprises Act Policies related to short-term, limited duration insurance Comments related to the Mental Health Parity and Addiction Equity Act Policies related to copay accumulator adjustor programs

Implementation of the No Surprises Act Blood and plasma safety and awareness Bleeding disorders awareness Issues related to plasma donation in border states Issues related to access to residential substance use disorder and mental health facilities for individuals with bleeding disorders Sickle Cell Care Expansion Act (H.R. 3100/S.1423) Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 3884/S. 1852) Menstrual Equity for All Act (H.R. 3646) Letter RE: House Budget Committees Health Care Task Force Request for Information on containing health care costs

Epilepsy Program Grants

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Medicare Part D, six protected classes of drugs

Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Policies related to insurance coverage and COVID-19 Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Safe Step Act (HR 2630 / S 652) Implementation of the No Surprises Act Policies related to short-term, limited duration insurance Patient Priorities for the Notice of Benefit and Payment Parameters

Hemophilia research, prevention, surveillance and service programs and issues Comments in response to Senate RFI re CDC

Support for policies which ensure health insurance provides comprehensive benefits and is affordable and accessible for patients Patient Priorities for the Notice of Benefit and Payment Parameters HR 824, the Telehealth Benefit Expansion for Workers Act

Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy

Policies related to health care and access to services for children and youth with special health care needs Activities related to being a Healthy People 2030 Champion Support for caregivers

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY24 House and Senate Labor-HHS Appropriations bills

Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472) Palliative Care and Hospice Education Training Act (PCHETA) (S. 2243) Comments in response to the discussion draft of the Stop Drug Shortages Act Letter to Congressional leadership related to drug shortages

Epilepsy Program Grants

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Request for subspecialty designation of epilepsy specialists (epileptologists) under Medicare ICD-10-CM proposals for epilepsy-related diagnosis codes Medicare Part D, six protected classes of drugs

Issues related to reimbursement for hemophilia services and treatments in Medicare Issuers related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act HR 3561 Section related to Medicaid transparency and drug pricing Comments in response to Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program and Value-Based Purchasing Program for Federal Fiscal Year 2024

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)

Policies related to health care and access to services for children and youth with special health care needs Activities related to being a Healthy People 2030 Champion Support for caregivers Provided input on Rare Disease Endpoint Advancement Pilot Program and Workshop

Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy

Clinical Trials Diversity Act Comments in response to Congressional RFI re CDC

Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472) Palliative Care and Hospice Education Training Act (PCHETA)

Issues related to reimbursement for hemophilia services and treatments in Medicare Issuers related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act HR 3561 Section related to Medicaid transparency and drug pricing Comments in response to Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program and Value-Based Purchasing Program for Federal Fiscal Year 2024

Funding for federal hemophilia programs

Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill

Implementation of the No Surprises Act Blood and plasma safety and awareness Bleeding disorders awareness Issues related to plasma donation in border states Issues related to access to residential substance use disorder and mental health facilities for individuals with bleeding disorders

Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Policies related to insurance coverage and COVID-19 Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Safe Step Act (HR 2630 / S 652) Implementation of the No Surprises Act Policies related to short-term, limited duration insurance

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Request for subspecialty designation of epilepsy specialists (epileptologists) under Medicare ICD-10-CM proposals for epilepsy-related diagnosis codes Medicare Part D, six protected classes of drugs

Epilepsy Program Grants

Comments in response to proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges Comments in response to Request for Information on Essential Health Benefits Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Policies related to prior authorization, including step therapy

Policies related to health care and access to services for children and youth with special health care needs Activities related to being a Healthy People 2030 Champion Support for caregivers

Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Reducing Hereditary Cancer Act (HR 1526/S. 765) CONNECT for Health Act Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Comments in response to proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges Comments in response to Request for Information on Essential Health Benefits Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Implementation of Lymphedema Treatment Act Preserving and expanding access to Medicaid Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses tissue from the lower abdomen to create a new breast

Funding for federal hemophilia programs

Issues related to reimbursement for hemophilia services and treatments in Medicare Issuers related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act

Issues related to participation in the 340B Drug Discount Program Comments on Proposed Changes to the 340B Administrative Dispute Resolution (Docket No. HRSA-2021-000X)

Implementation of the No Surprises Act Blood and plasma safety and awareness Bleeding disorders awareness Issues related to plasma donation in border states Issues related to access to residential substance use disorder and mental health facilities for individuals with bleeding disorders

Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Policies related to insurance coverage and COVID-19 Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Safe Step Act (HR 2630 / S 652) Implementation of the No Surprises Act Policies related to short-term, limited duration insurance Comments in response to proposed 2024 Notice of Benefit and Payment Parameters Comments in response to Request for Information on Essential Health Benefits

Submitted comments on Drug Enforcement Administration Notice of Proposed Rulemaking on the use of telemedicine to prescribe controlled substances.

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Request for subspecialty designation of epilepsy specialists (epileptologists) under Medicare ICD-10-CM proposals for epilepsy-related diagnosis codes Medicare Part D, six protected classes of drugs

Epilepsy Program Grants

Reintroduction of Sickle Cell Disease Comprehensive Care Act Request for a Center for Medicare and Medicaid Innovation demonstration program for sickle cell disease, including the Sickle Cell Disease Comprehensive Care Act

Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait Reintroduction of The Sickle Cell Care Expansion Act (H.R. 7177/S.4425) Healthcare issues related to hematologic diseases

Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding

Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research RFI on NIH-Wide Strategic Plan for Research on the Health of Women (Notice Number: NOT-OD-22-186) Advance Notice of Proposed Rulemaking: Trade Regulation Rule on Commercial Surveillance and Data Security (R111004)

Reproductive Health Services Interim Final Rule, RIN: 2900-AR57

Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research RFI on NIH-Wide Strategic Plan for Research on the Health of Women (Notice Number: NOT-OD-22-186) Advance Notice of Proposed Rulemaking: Trade Regulation Rule on Commercial Surveillance and Data Security (R111004)

Issues related to mifepristone

Appropriations for access to telehealth services for children and youth with special health care needs Appropriation for Telehealth Resource Centers program at HRSA Policies related to paid family and medical leave Appropriations for federal epilepsy activities Appropriations for NIH and CDC

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Section 1557, Nondiscrimination in Health Programs and Activities (RIN Number 0945-AA17) Supporting the Reauthorization of the Orphan Drug Program Declaration of National Epilepsy Awareness Month

Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067/ H.R. 5769) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act(HR 4612/S.2412) Safe Step Act (H.R. 2163/S. 464) The Closing Health Coverage Gaps for Public Servants Act (H.R. 7045/S. 3796) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act (S. 942) HELP Copays Act (H.R.5801), accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Comments in response to the RFI on Advanced Explanation of Benefits and Good Faith Estimate for Covered Individuals (CMS9900-NC) Implementation of the No Surprises Act

FDA policies related to research and approvals of treatments for hematological diseases

H.R. 2617 - Consolidated Appropriations Act of 2023 - NIH and funding of CDC sickle cell data collection program FY 2023 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding

S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act H.R. 2617 - Consolidated Appropriations Act of 2023 - Medicare provisions to eliminate cuts in physician payment and Medicaid provisions related to inclusion of S.3389/HR 6216. Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) Request for a Center for Medicare and Medicaid Innovation demonstration program for sickle cell disease

Hemophilia research, prevention, surveillance and service programs and issues

Implementation of the No Surprises Act Blood and plasma safety and awareness Bleeding disorders awareness Issues related to plasma donation in border states

Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act Coverage for Telehealth Services Closing the Medicaid coverage gap Issues related to 1115 Waivers in Medicaid Comments regarding the temporary increase in federal medical assistance percentage (FMAP) in response to the COVID-19 Public Health Emergency (PHE) (CMS-9912-N) Comments in response to the Medicaid Eligibility and Enrollment NPRM (CMS-2421-P) Comments in response to the RFI regarding National Directory of Healthcare Providers & Services (CMS-0058-NC) Comments in response to the RFI regarding accessing healthcare and related challenges, understanding provider experiences, advancing health equity, and assessing the impact of waivers and flexibilities provided in response to the COVID-19 Public Health Emergency (PHE)

Epilepsy Program Grants

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Medicare Part D, six protected classes of drugs HR 3173, Improving Seniors Timely Access to Care Act

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)

Issues related to participation in the 340B Drug Discount Program

Funding for federal hemophilia programs

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to paid family and medical leave Policies related to development of the Advanced Research Projects Agency for Health Supplemental appropriations for COVID-19-related relief, the production of monoclonal antibodies, availability of testing, etc Addition in any reconciliation package of policies related to health insurance coverage and affordability, including permanent extension of Advanced Premium Tax Credits provided by the American Rescue Plan, closing the Medicaid coverage gap, and a cap on out-of-pocket costs for Medicare Part D beneficiaries

Breast cancer research at the Department of Defense H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023; a bill to authorize Department of Defense activities and programs for FY 2023

FY 2023 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding

FDA policies related to research and approvals of treatments for hematological diseases

S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2023 Rates Comments in response to CY2023 Medicare Physician Fee Schedule (CMS-1770-P) National Coverage Determination on myelodysplastic syndromes (MDS) Issues related to Medicare coverage of childhood vaccines for patients post-stem cell transplant

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Input on federal policies that contribute to racial and ethnic health inequities, as well as potential solutions that could improve health equity Request for Applications for New Members of the Clinical Trials Transformation Initiative/Food and Drug Administration Patient Engagement Collaborative [Docket No. FDA-2017-N-6395]

Appropriations for access to telehealth services for children and youth with special health care needs Appropriation for Telehealth Resource Centers program at HRSA Policies related to paid family and medical leave

Issues related to mifepristone

Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum Graduate medical education

Reproductive Health Services Interim Final Rule, RIN: 2900-AR57

Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act Coverage for Telehealth Services Closing the Medicaid coverage gap Issues related to 1115 Waivers in Medicaid Request for Information: Access to Coverage and Care in Medicaid and CHIP

Funding for federal hemophilia programs in FY 22 Labor, HHS, and Education Appropriations Policies related to paid family and medical leave

H.R. 5376 - Inflation Reduction Act of 2022; a budget reconciliation bill which included provisions to continue subsidies on private insurance premiums, address out of pocket costs in Medicare Part D, and more Comments on future rulemaking for the 2024 Notice on Benefit and Payment Parameters Implementation of the Affordable Care Act The HELP Copays Act (HR 5801) Policies related to insurance coverage and COVID-19 Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Safe Step Act (HR 2163 / S 464) Policies to make Advance Premium Tax Credits Permanent Implementation of the No Surprises Act Addition in any reconciliation package of policies related to health insurance coverage and affordability, including permanent extension of Advanced Premium Tax Credits provided by the American Rescue Plan, closing the Medicaid coverage gap, and a cap on out-of-pocket costs for Medicare Part D beneficiaries Policies related to short-term, limited duration insurance

Epilepsy Program Grants

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Medicare Part D, six protected classes of drugs HR 3173, Improving Seniors Timely Access to Care Act

Issues related to participation in the 340B Drug Discount Program

Funding for federal hemophilia programs

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Comments on future rulemaking for the 2024 Notice on Benefit and Payment Parameters The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)

Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research

Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum

Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum

Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Comments on the Affordability of Employer Coverage for Family Members of Employees Submission of telehealth and whole genome sequencing as topics for evidence review NOT-TR-21-027 - Request for Information (RFI): Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases

Policies related to development of the Advanced Research Projects Agency for Health

Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act(HR 4612/S.2412) Safe Step Act (H.R. 2163/S. 464) The Closing Health Coverage Gaps for Public Servants Act (S. 3796) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act (S. 942) HELP Copays Act (H.R.5801), accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies regarding White House Cancer Moonshot implementation Issues related to regulation of short-term limited duration plans Comments on the Affordability of Employer Coverage for Family Members of Employees

Multi-Cancer Early Detection Screening Coverage Act (HR 1946/S 1873) Lymphedema Treatment Act (HR 3630/ S 1315) Breast Cancer Patient Equity Act (HR 3087/S 2051) Reducing Hereditary Cancer Act of 2021 (HR 4110) CONNECT for Health Act (S.1512/ H.R. 2903) Improving Seniors' Timely Access to Care Act (H.R.3173) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Seniors Prescription Drug Relief Act (S.2327) Medicare coverage policy for breast cancer treatments and services Radiation Oncology Alternative Payment Model Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services and the Equitable Community Access to Pharmacist Services Act (H.R.7213) Issues related to the upcoming Notice on Benefit and Payment Parameters for FY2024 Medicare coverage policy for drugs and drug pricing Comments in response to CMS Request for Information on Access to Coverage and Care in Medicaid and Chip

Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait Issues related to Sickle Cell Disease Treatment Centers 2021 Sickle Cell Disease Awareness Month Resolution The Sickle Cell Care Expansion Act (H.R. 7177/S.4425) Healthcare issues related to hematologic diseases CURES 2.0 draft legislation (H.R. 6000) Implementation of No Surprises Act Affordability of Employer Coverage for Family Members of Employees (REG-114339-21)

S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) Issues related to Medicare coverage of childhood vaccines for patients post-stem cell transplant

Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act CMS-1765-P; Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)

Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act Coverage for Telehealth Services Closing the Medicaid coverage gap Issues related to 1115 Waivers in Medicaid CMS-1765-P; Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities Request for Information: Access to Coverage and Care in Medicaid and CHIP

Implementation of the Affordable Care Act The HELP Copays Act (HR 5801) Policies related to insurance coverage and COVID-19 Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Safe Step Act (HR 2163 / S 464) Policies to make Advance Premium Tax Credits Permanent Implementation of the No Surprises Act Addition in any reconciliation package of policies related to health insurance coverage and affordability, including permanent extension of Advanced Premium Tax Credits provided by the American Rescue Plan, closing the Medicaid coverage gap, and a cap on out-of-pocket costs for Medicare Part D beneficiaries Policies related to short-term, limited duration insurance DHS Docket No. USCIS-2021-0013; Public Charge Ground of Inadmissibility Affordability of Employer Coverage for Family Members of Employees

Epilepsy Program Grants

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Medicare Part D, six protected classes of drugs HR 3173, Improving Seniors Timely Access to Care Act

Policies related to development of the Advanced Research Projects Agency for Health

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Response to Requests for Information from the Healthy Futures Task Force Response to White House RFI on Strengthening Community Health Through Technology

Breast cancer research at the Department of Defense H.R. 4350/S. 1605 - National Defense Authorization Act for Fiscal Year 2022; a bill to authorize Department of Defense activities and programs for FY 2022

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations report language related to metastatic breast cancer Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to paid family and medical leave Public Health Infrastructure Saves Lives Act (S 674) Rise Act (HR 869/S 289) Build Back Better Act (HR 5376) Policies related to development of the Advanced Research Projects Agency for Health Supplemental appropriations for COVID-19-related relief, the production of monoclonal antibodies, availability of testing, etc

FDA policies related to research and approvals of treatments for hematological diseases

FY 2022 and FY 2023 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding

S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) The Sickle Cell Care Expansion Act (H.R. 7177)

Funding for federal hemophilia programs

Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)

Issues related to participation in the 340B Drug Discount Program

Implementation of the No Surprises Act Blood and plasma safety and awareness Bleeding disorders awareness Issues related to plasma donation in border states

Hemophilia research, prevention, surveillance and service programs and issues

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program Protect 340B Act (HR 4390)

Reimbursement for healthcare services provided by epilepsy centers Telehealth services Medicare Part D, six protected classes of drugs HR 3173, Improving Seniors Timely Access to Care Act

Epilepsy Program Grants

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers

Policies related to development of the Advanced Research Projects Agency for Health

Appropriations for access to telehealth services for children and youth with special health care needs Build Back Better Act (HR 5376) Policies related to paid family and medical leave

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations report language related to metastatic breast cancer Appropriations for breast cancer research Policies related to paid family and medical leave Public Health Infrastructure Saves Lives Act (S 674) Rise Act (HR 869/S 289) Build Back Better Act (HR 5376)

Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act(S.2412) Safe Step Act (H.R. 2163/S. 464) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act HELP Copays Act (H.R.5801), accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients

FDA policies related to research and approvals of treatments for hematological diseases

FY 2022 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding

Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait 2021 Sickle Cell Disease Awareness Month Resolution Healthcare issues related to hematologic diseases CURES 2.0 draft legislation (H.R. 6000) Responding to Social Determinants of Health Caucus Request for Information Implementation of No Surprises Act

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program Protect 340B Act (HR 4390)

Funding for federal hemophilia programs in FY 22 Labor, HHS, and Education Appropriations Build Back Better Act (HR 5376) Policies related to paid family and medical leave

Implementation of the Affordable Care Act The HELP Copays Act (HR 5801) Policies related to insurance coverage and COVID-19 Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Safe Step Act (HR 2163 / S 464) Policies to make Advance Premium Tax Credits Permanent Implementation of the No Surprises Act